American Healthcare REIT, Inc. (AHR)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $13.41B
Last updated: Nov 17, 2026 at 11:05 AM ET
American Healthcare REIT, Inc. (AHR) Financials: Revenue, Profit and Cash Flow
American Healthcare REIT reported revenue of $2.26B for the fiscal year ended Dec 31, 2025, up 9.1% from the year before. That year, net income was $69.81M with a net margin of 3.1%, operating cash flow was $294.44M and free cash flow was $165.88M. The quarter ended Sep 30, 2026 had revenue of $742.15M and net income of $31.21M.
Revenue and Margins
The operating margin was 7.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $980.29M, a compound annual rate of 9.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.26B | +9.1% | 20.6% | 7.5% | 3.1% |
| Dec 2024 | $2.07B | +11.4% | 20.1% | 6.6% | -1.8% |
| Dec 2023 | $1.86B | +14.9% | 19.2% | 4.1% | -3.8% |
| Dec 2022 | $1.62B | +28.0% | 20.8% | 5.6% | -5.0% |
| Dec 2021 | $1.26B | +6.7% | 14.4% | 11.0% | -3.8% |
| Dec 2020 | $1.18B | -3.0% | 13.4% | 11.1% | 0.2% |
| Dec 2019 | $1.22B | +7.9% | 18.0% | 15.5% | -0.4% |
| Dec 2018 | $1.13B | +7.8% | 18.3% | 15.8% | 1.2% |
| Dec 2017 | $1.05B | +7.0% | 20.2% | 17.1% | 1.1% |
| Dec 2016 | $980.29M | N/A | 18.4% | 15.5% | -14.9% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income fell 44.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.26B | $2.07B | $1.86B | $1.62B | $1.26B | $1.18B | $1.22B | $1.13B | $1.05B | $980.29M |
| Cost of revenue | $1.79B | $1.65B | $1.50B | $1.28B | $1.08B | $1.03B | $1.00B | $923.82M | $837.64M | $800.10M |
| Gross profit | $466.59M | $416.77M | $356.83M | $335.97M | $182.01M | $158.58M | $219.30M | $207.56M | $211.60M | $180.19M |
| Operating income | $168.87M | $136.78M | $76.72M | $90.59M | $138.81M | $131.57M | $189.55M | $179.14M | $179.43M | $151.51M |
| Net income | $69.81M | -$37.81M | -$71.47M | -$81.30M | -$47.79M | $2.16M | -$4.96M | $13.30M | $11.22M | -$146.03M |
| EBITDA | $359.62M | $315.48M | $324.26M | $233.76M | $163.00M | $162.36M | $222.28M | N/A | N/A | $157.60M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $742.15M | $674.25M | $650.77M | $604.08M | $572.94M | $542.50M | $540.60M | $542.74M | $523.81M | $504.58M | $499.53M | $482.55M |
| Gross profit | $164.79M | -$7.01M | $138.60M | $123.79M | $118.41M | $116.22M | $108.18M | $112.17M | $106.69M | $102.02M | $95.90M | $97.54M |
| Operating income | $47.23M | $45.58M | $40.84M | $39.73M | $42.53M | $46.34M | $40.27M | $40.15M | $37.37M | $31.68M | $27.58M | $29.21M |
| Net income | $31.21M | $30.61M | $23.71M | $10.78M | $55.93M | $9.91M | -$6.80M | -$31.77M | -$4.13M | $1.98M | -$3.89M | -$27.43M |
Balance Sheet
As of Dec 2025, total debt of $1.55B exceeded cash and equivalents by $1.44B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.43B | $4.49B | $4.58B | $4.79B | $4.58B | $3.23B | $3.17B | $2.89B | $2.80B | $2.79B |
| Current assets | $319.15M | $354.89M | $297.10M | $341.92M | $330.74M | $356.95M | $331.44M | $303.29M | $275.51M | $269.55M |
| Cash and equivalents | $114.84M | $76.70M | $43.45M | $65.05M | $81.60M | $113.21M | $53.15M | $35.13M | $33.66M | $29.12M |
| Total liabilities | $2.07B | $2.18B | $3.12B | $3.14B | $2.75B | $2.16B | $2.07B | $1.63B | $1.42B | $1.34B |
| Short-term debt | $549.76M | $688.53M | $1.45B | $316.73M | $921.90M | $1.65B | $8.32M | $3.31M | $95.28M | $37.61M |
| Long-term debt | $1.00B | $1.02B | $1.34B | $1.28B | $1.13B | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $3.32B | $2.26B | $1.27B | $1.40B | $1.58B | $866.11M | $900.55M | $1.06B | $1.19B | $1.26B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.61B | $5.70B | $5.60B | $5.43B | $4.77B | $4.51B | $4.46B | $4.49B | $4.68B | $4.64B | $4.70B | $4.58B |
| Total liabilities | $1.96B | $1.96B | $2.08B | $2.07B | $2.05B | $2.04B | $2.16B | $2.18B | $2.42B | $2.54B | $2.56B | $3.12B |
| Cash and equivalents | $222.77M | $156.90M | $119.38M | $114.84M | $147.36M | $133.49M | $86.06M | $76.70M | $67.85M | $52.09M | $77.03M | $43.45M |
| Shareholder equity | $5.54B | $3.69B | $3.48B | $3.32B | $2.68B | $2.42B | $2.26B | $2.26B | $2.21B | $1.93B | $1.96B | $1.27B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 56.3% of operating cash flow. Dividends came to 98.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $294.44M | $176.09M | $98.53M | $147.77M | $17.91M | $219.16M | $117.45M | $106.81M | $128.10M | $114.36M |
| Capital expenditures | $128.56M | $91.94M | $99.79M | $71.52M | $79.69M | $128.30M | $92.84M | $66.91M | $43.55M | $45.98M |
| Free cash flow | $165.88M | $84.15M | -$1.26M | $76.25M | -$61.78M | $90.85M | $24.62M | $39.91M | $84.55M | $68.37M |
| Dividends paid | $163.52M | $120.89M | $76.28M | $51.12M | $22.79M | $27.00M | $62.61M | $59.97M | $55.78M | $51.68M |
| Investing cash flow | -$1.08B | -$8.73M | $9.40M | -$118.58M | -$138.65M | -$147.94M | -$103.11M | -$135.77M | -$124.55M | -$352.69M |
| Financing cash flow | $817.50M | -$134.74M | -$129.06M | -$42.92M | $94.11M | -$8.81M | $2.69M | $37.60M | $4.76M | $226.66M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $166.89M | $118.62M | $81.07M | $55.16M | $107.19M | $71.47M | $60.62M | $59.51M | $63.13M | $59.40M | -$5.95M | $25.77M |
| Capital expenditures | $65.36M | $47.69M | $38.32M | $69.26M | $48.08M | $26.90M | $21.18M | $29.68M | $23.88M | $18.49M | $19.89M | $25.41M |
| Free cash flow | $101.53M | $70.93M | $42.75M | -$14.09M | $59.11M | $44.58M | $39.44M | $29.82M | $39.25M | $40.91M | -$25.84M | $364.00K |
Frequently Asked Questions About AHR
What is American Healthcare REIT's annual revenue?
American Healthcare REIT reported revenue of $2.26B for the fiscal year ended Dec 31, 2025.
How fast is American Healthcare REIT's revenue growing?
Revenue was up 9.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.8%.
Is American Healthcare REIT profitable?
Yes. American Healthcare REIT reported net income of $69.81M for the fiscal year ended Dec 31, 2025, with a net margin of 3.1%.
How much free cash flow does AHR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $294.44M minus capital expenditures of $128.56M produced free cash flow of $165.88M.
How much debt does American Healthcare REIT have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.00B, short-term debt of $549.76M and cash and equivalents of $114.84M.
AHR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors